The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Strategies for targeting senescent cells in human disease
Open accessAbstract
Cellular senescence represents a distinct cell fate characterized by replicative arrest in response to a host of extrinsic and intrinsic stresses. Senescence provides programming during development and wound healing, while limiting tumorigenesis. However, pathologic accumulation of senescent cells is implicated in a range of diseases and age-associated morbidities across organ systems. Senescent cells produce distinct paracrine and endocrine signals, causing local tissue dysfunction and exerting deleterious systemic effects. Senescent cell removal by apoptosis-inducing "senolytic" agents or therapies that inhibit the senescence-associated secretory phenotype, SASP inhibitors, have demonstrated benefit in both pre-clinical and clinical models of geriatric decline and chronic diseases, suggesting senescent cells represent a pharmacologic target for alleviating effects of fundamental aging processes. However, senescent cell populations are heterogeneous in form, function, tissue distribution, and even differ among species, possibly explaining issues of bench-to-bedside translation in current clinical trials. Here, we review features of senescent cells and strategies for targeting them, including immunologic approaches, as well as key intracellular signaling pathways. Additionally, we survey current senolytic therapies in human trials. Collectively, there is demand for research to develop targeted senotherapeutics that address the needs of the aging and chronically-ill.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Through upregulation of pro-survival and antiapoptotic pathways such as SRC kinases, the PI3K-AKT signaling pathway, heat shock protein (HSP) pathways, serpines, mitochondrial pathways or apoptosis regulator BCL-2-related proteins, those senescent cells with a proapoptotic SASP can survive, despite the cytotoxic microenvironment they create6,7,14,34,35,54–58.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“but also enhance SASP autocrine loop, as found in multiple previous studies,124,125,126,127”
From Single-cell senescence identification reveals senescence heterogeneity, trajectory, and modulators (2024) · cites this paper as [127]
Experimental — accuracy not yet measuredIn the citing paper
“Persistent senescent cells are known to exert detrimental long-term effects on organ function and can promote tumorigenesis33,96,112,177,178.”
From COVID-19 and cellular senescence (2023) · cites this paper as [96]
In the citing paper
“Senescent cells are highly associated with aging and pathological conditions and could be targeted to slow the aging process.”
From The heterogeneity of cellular senescence: insights at the single-cell level (2023) · cites this paper as [3]
In the citing paper
“At the transcript level, p16 and p21 are the two most commonly used markers for senescent cells [3,16].”
From The heterogeneity of cellular senescence: insights at the single-cell level (2023) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kaur, A., Webster, M. R., Marchbank, K., Behera, R., Ndoye, A., Kugel, C. H., Dang, V. M., Appleton, J., O’Connell, M. P., Cheng, P., et al. (2016) · Nature · doi:10.1038/nature17392 · Cited by 398
RetractedThe serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
Franceschi, C., & Campisi, J. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu057 · Cited by 3,891
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Self-citationCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
Self-citation
Cited by
Sorted by citations
Items 401–500 of 500
Payea, M. J., Dar, S. A., Anerillas, C., Martindale, J. L., Belair, C., Munk, R. B., Malla, S., Fan, J., Piao, Y., Yang, X., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.12.536613 · Cited by 2
Jang, D., Shim, E., Shin, J., Kim, S., Ciotlos, S., Kim, H. J., Gil, T., Kim, Y., & Jeon, O. H. (2026) · Aging Cell · doi:10.1111/acel.70540 · Cited by 2
“This heterogeneity complicates their molecular characterization and may limit the efficacy of senolytic therapies designed to selectively eliminate harmful SnCs (Gasek et al. 2021).”
Molecular basis of senescence in osteoarthritis
Lawson, M. G., & Ritchison, H. M. (2024) · doi:10.32948/ajsep.2024.11.22 · Cited by 2
“…to the inflammatory state through the release of SASP-factors, including pro-inflammatory cytokines (interleukin-1 (IL-1), IL-8, tumor necrosis factor-alpha (TNF-α)), matrix metalloproteinases (MMPs), microRNAs (miRNAs), growth factors, and metabolites, into the tissue microenvironment [13].”
Impacts of Senolytic Phytochemicals on Gut Microbiota: A Comprehensive Review
Kim, H. S., & Jung, C. H. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2408.08032 · Cited by 1
“Senolytics suppress SASP expression by selectively removing senescent cells and retaining healthy cells [3].”
Senescence and Neurodegenerative Disorders: Beyond Alzheimer’s and Parkinson’s
Tiwari, I., Chauhan, P., Singh, A., & Sharma, N. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-1041-9_7 · Cited by 1
Zhang, Y., Shen, M., Zhang, B., Li, X., Cheng, H., Feng, D., Han, Y., Luo, Z., & Zhou, Y. (2025) · The FASEB Journal · doi:10.1096/fj.202403361r · Cited by 3
Mesothelin-Associated Anti-Senescence Through P53 in Pancreatic Ductal Adenocarcinoma
Liu, D., Lü, J., Chen, C., & Yao, Q. C. (2025) · Cancers · doi:10.3390/cancers17122058 · Cited by 1
Senescence and Beyond: Exploring Senolytic Strategies for Chronic Disease
Srivastava, M., Ampeti, S., Sheikh, R. B., Kirankumar, P. N., & Sali, S. R. (2025) · medtigo Journal of Medicine · doi:10.63096/medtigo30612313 · Cited by 1
Ke, R.-S., Zhang, W.-H., Tu, Y.-L., Liu, Z.-H., Zhang, F.-X., & Huang, K.-Z. (2025) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2025-0223 · Cited by 1
“Not only does microbiome-mediated cellular senescence regulate senescent cell-mediated gut homeostasis, it also modulates disease changes [10, 12].”
Martins-Silva, R., Kaizeler, A., & Barbosa‐Morais, N. L. (2026) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqag057 · Cited by 1
“…(i.e. senescence scores decrease from proliferative to senescent samples, compared to other cell types), possibly reflecting the unique, post-mitotic nature of neurons and their non-canonical, senescence-like phenotype (cell-cycle arrested but metabolically and secre-8 torily active) [ 10 , 37 ].”
Wei, Z., Li, Z., & Quan, N. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1702207 · Cited by 1
“As a key senescence marker alongside p21 (Gasek et al., 2021; Wang et al., 2022), p16 can be induced by ROS and other stressors (Chen et al., 2015).”
The Biological Mechanisms of Frailty: Focusing on Cellular Senescence
Erusalimsky, J. D. (2026) · European Cardiology Review · doi:10.15420/ecr.2025.81 · Cited by 1
“26 These include telomere damage, persistent DNA damage signalling, increased expression of the cell-cycle inhibitors p21 and p16, mitochondrial dysfunction, increased generation of reactive oxygen species, changes in chromatin structure, cellular hypertrophy, increase in lysosomal mass and…”
Dey, A., Nethaji, K., Banerjee, A., Duss, R., Pathak, S., & Duttaroy, A. K. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107283 · Cited by 2
The Roles of Macrophage Lineage Cells ( MLC s) in Brain Aging
Qin, Q., Zhang, L., Guo, M., Lu, D., Liu, Y., Wang, Z., Hu, M., Wang, S., Kang, X., Yi, H., et al. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70873 · Cited by 1
Bhavya, R., & Sandur, R. (2026) · Immunological Investigations · doi:10.1080/08820139.2026.2695165 · Cited by 1
“Additionally senescent cells may evade immune clearance by expressing immunomodulatory surface receptors and recruiting immunosuppressive cells, which results in diminished cytotoxic capacity and compromised elimination of tumor cells and pathogens (Gasek et al., 2021).”
Mai, V.-H., Lê, T. T. M., Choi, S., Seong, G.-H., Cha, H., Lee, Y., & Oh, W. K. (2026) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6c00589 · Cited by 1
Alexander, P. G., Yan, B., Clark, K. L., Dong, Q. D., Wang, D., Yang, Y., Zhang, T., Zhang, P., Zheng, G., Robbins, P. D., et al. (2026) · Aging · doi:10.18632/aging.206394 · Cited by 1
“A defining characteristic of SnCs is their resistance to apoptotic cell death [26, 27].”
Shi, P., Yang, Z.-R., Wu, W., Cheng, Z., Gao, H., Chen, Y., Chen, X., Yang, C., Zhu, J., Jiang, H., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124454 · Cited by 1
The Physical Senotype in cellular senescence: Mechanical and physical strategies for senotherapy
Wang, B., Qi, X., Huard, J., & Mu, X. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103283 · Cited by 1
Tabula Sapiens 2.0: A comprehensive transcriptomic atlas of human cell types
Jones, R. C., Krasnow, M. A., Pisco, A. O., Quake, S. R., Salzman, J., Yosef, N., Mantri, M., Thieme, A., Aguirre, J., Garner, R., et al. (2026) · Cell · doi:10.1016/j.cell.2026.08.010 · Cited by 3
Adnot, S., Bernard, D., Lipskaia, L., & Trottein, F. (2023) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2022.11.011 · Cited by 1
Advances in anti-aging research of urine-derived stem cells
Zhong, X., Suo, H., Lu, Z.-K., Liu, Z.-K., Liu, Z., Wang, C., Li, C., Zhang, J., Liu, J., & Sun, J. (2024) · New cell · doi:10.61958/ncyq8589 · Cited by 1
The Role of Methyltransferase SETD7 in Stress-Response of Normal Human Stromal Cells
Konyushatova, А. О., Deryabin, P. I., Shatrova, A. N., & Borodkina, A. V. (2025) · Cell and Tissue Biology · doi:10.1134/s1990519x25010080 · Cited by 1
“The latter fact is quite remarkable in the context of the search for new compounds with senolytic activity, in other words, compounds that allow targeted killing of senescent cells (Borghesan et al., 2020; Gasek et al., 2021).”
Misale, S., Yaeger, R. D., Mezzadra, R., Sinopoli, J. C., Bian, Y., Marasco, M., Kaplun, E., Gao, Y., Zhao, H., Paula, A. D. C., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1236956/v1 · Cited by 1
Gerontogen as the Toxicology of AgingPreprint
Rahma, R., & Barinda, A. J. (2024) · Preprints.org · doi:10.20944/preprints202404.0659.v1 · Cited by 1
Hsu, J.-E., Wang, B., Hwang, Y., Cheng, W., Zhao, Q., Si, Y., Xu, M., Kang, H.-M., & Lee, J. H. (2026) · Biomolecules · doi:10.3390/biom16040579
“Cellular senescence is a regulated aging process in which cells remain viable yet undergo stable cell-cycle arrest and acquire metabolic changes that can reshape tissue homeostasis [1,2].”
Self-citationThe 6th international cell senescence association conference
Kawamoto, S., Matsumoto, T., Takasugi, M., & Hara, E. (2022) · Genes to Cells · doi:10.1111/gtc.12970
Pillai, R. K., Miró‐Mur, F., Alijotas‐Reig, J., Tchkonia, T., Schwartz, S., Kirkland, J. L., & Oshima, J. (2022) · Research Square · doi:10.21203/rs.3.rs-2106211/v1
Self-citationResearch progress and prospect of aging mechanism and anti-aging
Tian, H. (2022) · International Conference on Biomedical and Intelligent Systems (IC-BIS) · doi:10.1117/12.2660284
“At present, popular strategies for removing senescent cells mainly include immune cell usage, SASP neutralization, senolytics (senescent cell lysis agent) usage [29], senomorphics (suppression of SASP) and more emerging exosome therapy [30].”
BackgroundSenotherapy as a Novel Therapeutic Method in Cancer Treatment: With a Focus on Head and Neck Cancer
Ziaei, H., & Harada, H. (2023) · Interdisciplinary cancer research · doi:10.1007/16833_2022_118
Mechanismen der Nierenalterung
Melk, A., Grabitz, C., & Schmitt, R. (2023) · Springer eBooks · doi:10.1007/978-3-662-65648-8_3
Effect of DNA damage mediating psychosocial stress on aging
Al-Maeni, M., & Al-Khazraji, S. F. R. (2023) · Iraqi Journal of Cancer and Medical Genetics · doi:10.29409/ijcmg.v16i1.271
Liu, S., Zhang, J., Zhang, J., Wang, J., Chen, Y., He, Q., Li, X., Liu, T., Guan, Y., Zhang, P., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3913972/v1
Aqp1 Differentially Orchestrates Endothelial Cell SenescencePreprint
Shabanian, K., Shabanian, T., Karsai, G., Lettlová, S., Pontiggia, L., Ruschitzka, F. T., Beer, J. H., & Saravi, S. S. S. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4818945
Current Research About Senotherapeutics
Bennett, G. (2024) · SpringerBriefs in modern perspectives on disability research. · doi:10.1007/978-981-97-3637-9_3
Chau, M. M., & Mandelbaum, B. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822902-6.00012-x
Tea epigallocatechin gallate and impact on life span
Sharma, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14158-4.00007-5
Баландин, А. А., Kobeleva, A. S., Баландина, И. А., & Gulyaeva, N. I. (2024) · Bulletin of the Medical Institute REAVIZ (REHABILITATION DOCTOR AND HEALTH) · doi:10.20340/vmi-rvz.2024.4.morph.2
Tan, D., Xu, C., Zhu, Q., Fan, G., & Luo, Q. (2024) · Aging and Disease · doi:10.14336/ad.2024.1262r
“Senescent cells exhibit morphologic alterations and metabolic reprogramming, and produce a highly active secretome known as the senescence-associated secretory phenotype (SASP) [3], which can lead to local tissue dysfunction and systemic effects [4].”
Targeting the hypothalamic MC4 receptor: A novel approach to senolytic therapy?
Kim, Y. J., Lim, J. H., & Kim, E. R. (2024) · Medical Hypotheses · doi:10.1016/j.mehy.2024.111551
Microglia Adopt Temporally Specific States after Irradiation, Correlating with Neuronal AsynchronyPreprint
Romero, A. L., Preka, E., Pizzirusso, G., Arroyo‐García, L. E., Zisiadis, G. A., Oliva‐Vilarnau, N., Ruchiy, Y., Seitz, T., Zhou, K., Isla, A. G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.15.638339
Du mosaïcisme cérébral aux crises d’épilepsie
Ribierre, T., & Baulac, S. (2025) · médecine/sciences · doi:10.1051/medsci/2025053
Enjeux de santé publique du vieillissement de la population : les nonagénaires
Ankri, J. (2025) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2025.02.015
Ma, L., Li, H., Li, Y., Lin, Z.-A., Li, J., Zhang, Y., Zhang, P., Yao, Z., Li, J., Xiong, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.11.681821
Sharma, R. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152881
Blood aging: From definition and mechanisms to clinical practice
Yin, Q., Zhang, Y., Yi, X., Li, J., Dai, Y., & Jin, F. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112144
Wang, Y., Ou, A., Luo, Y., Gao, Y., Zhang, Y., Qin, L., & Huang, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.15.694320
Wang, W., Peng, H., Zeng, M., Liu, J., Liang, G., & He, Z. (2023) · Figshare · doi:10.6084/m9.figshare.24761381
Wang, W., Peng, H., Zeng, M., Liu, J., Liang, G., & He, Z. (2024) · Figshare · doi:10.6084/m9.figshare.24761932
Wang, W., Peng, H., Zeng, M., Liu, J., Liang, G., & He, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26650344
Behboodpour, L., Adeli, F., Emisoglu-Kulahli, H., Meran, A., Latifi, Z., & Abbasi, F. (2026) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c04850
Radiation‑Induced Microglial Turnover Elicits a cGAS‑Mediated Interferon ResponsePreprint
Blomgren, K., Preka, E., Romero, A. L., Canut, M. Q., Tamvaki, K. M., Oliva‐Vilarnau, N., Zhou, K., Onetti, Y., Sandner, S., Greer, A., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8775672/v1
SENOLYTICS – A DISCOVERY THAT COULD TRANSFORM THE COURSE OF AGING AND CHRONIC DISEASES
Kania, K., Bobiński, M., Wieczorek, Z., Skowron, W., Bartol, J., Sosińska, A., Rajczyk, J., Wiczuk-Wiczewska, M., Szymczak, A., & Lepich, T. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.1(49).2026.5128
Microglial senescence and senolytic drugs
Ben-Azu, B., Sabbah, S., Awogbindin, I. O., Chidebe, E. O., Oritsemuelebi, B., Patel, D., Frenkel, D., & Tremblay, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27340-7.00010-3
Liang, K., Hu, M., Zhao, H., Xu, W., Zhang, Y., He, R., Peng, C., Chen, H., Ju, Z., Wu, S., et al. (2026) · Frontiers in Chemistry · doi:10.3389/fchem.2026.1771968
“Secondly, senescent cells secrete a large quantity and a variety of inflammatory factors known as the senescence-associated secretory phenotype (SASP) (Gasek et al., 2021).”
Nanocatalytic regulation of age-related diseases
Li, J., Wu, L., Yu, L., Xie, Y., Da, J., & Liu, Y. (2026) · Chemical Communications · doi:10.1039/d6cc00437g
Wang, Y., Ou, A., Luo, Y., Gao, Y., Zhang, Y., Qin, L., & Huang, Y. (2026) · eLife · doi:10.7554/elife.110069.1
Demethyleneberberine alleviates cellular senescence of human fibroblasts by directly activating FEN1
Jiang, M., Yan, X., Zhang, P., Guo, P., Hu, R., Zhai, W., Xu, Q., Hu, S., Churov, A. V., & Wu, Z. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119252
Wang, Y., Ou, A., Luo, Y., Gao, Y., Zhang, Y., Qin, L., & Huang, Y. (2026) · eLife · doi:10.7554/elife.110069
Zhang, X., Yang, L., He, X., Zhao, M., Fang, Z., Xu, G., Duan, Z., & Luo, K. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.03.050
“For instance, combining senescence-targeting strategies with immunotherapy can simultaneously clear senescent cells and activate anti-cancer immunity 259 .”
Xu, H., Lin, Q., Ni, W.-P., Ge, J., & Sun, R. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c07794
Reversing PROTAC-induced ASH2L degradation reactivates proliferation in senescent cellsPreprint
Müller, J., Barsoum, M., Bussmann, P., Mabrouk, M. H. E., Sayadi-Boroujeni, R., Vllaho, A.-M., Stenzel, A. T., Vogt, L., Kießling, P., Kuppe, C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.02.722411
de Almeida, A. J. P. O., Pontes, L. V. D. S., Júnior, J. F. D. S., Soares, E. M. C., dos Santos, A. C., Gonçalves, T. A. F., Feitosa, M. S. D. A., Veras, R. C., Barbosa‐Filho, J. M., Lesniewski, L. A., et al. (2026) · Molecules · doi:10.3390/molecules31101614
“Therefore, the development of therapies that aim to reduce the deleterious consequences of senescence burden is necessary for the clinic [34,35].”
Wang, C., Wang, C., Wu, S., Shi, L., Dai, C., Hu, R., Chen, Y., & Zhang, R. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.05.022
“The development of models/drugs that can selectively destroy the senescent cells offered additional evidence that senescent cells could serve as a viable therapeutic target [19,20].”
Shao, Q., Chen, D., Shao, W., & Ye, Q. (2026) · Research · doi:10.34133/research.1326 · Cited by 1
“Therefore, targeted elimination of aging cells with high specificity or inhibition of their harmful secretions has become important as a next-generation weapon against biological aging [ 11 ].”
Li, X. D., Ma, G., Wang, F., Ding, Z., Chen, Y., Cheng, S., Pang, W., Chen, L., & Cao, H. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.05.015
An, X., Wu, T., Gou, R., & Fang, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1835582
“Cellular senescence is a key factor in aging and age-related diseases (3).”
Chen, X., Liu, H., Shu, Q., Tang, Y., Zhang, J., Yu, W., & Li, S. (2026) · Cells · doi:10.3390/cells15121123
“For instance, combining senolytics or senomorphics with immunotherapy, chemotherapy, or radiotherapy may exert synergistic effects in selected patient subgroups, thus improving overall treatment response rates and clinical outcomes [120,151,152].”
Chen, D., & Xiang, F. (2026) · Canadian Respiratory Journal · doi:10.1155/carj/6653364
“Multiple studies have demonstrated that senolytic therapies targeting senescent endothelial cells can partially alleviate PF [142].”
Zuo, Q., Huang, K., Huang, R., Bao, Z., Tan, Y., Zhang, Y., Zhao, R., Li, Q., Yang, P., & Liu, J. W. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103249
Hasegawa, T., Nishitani, K., & Kabashima, K. (2026) · International Immunology · doi:10.1093/intimm/dxag037
Chen, Y., Zhu, D., Xu, W., Miao, X., & Jiang, Z. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.07.020
Vrablikova, K., Hoza, P., Párová, H., Rybar, M., Kaur, J., Khosla, S., Monroe, D. G., Mikyskova, P. S., & Palička, V. (2026) · Physiological Research · doi:10.33549/physiolres.935778
“The most recent breakthrough, clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR-Cas9), has led to the first CRISPR-based gene therapies approved by the FDA and EMA for monogenic diseases [15-19].”
Wang, L. W., Wan, Y., Wu, L., Cao, H., Xiong, X., Zhai, X., Wang, B., Cai, B., Zhang, D., & Kuang, X. (2026) · Toxicology · doi:10.1016/j.tox.2026.154548
Song, Y., Zhang, R., Zhang, X., Wang, J., Chen, J., & Li, L. (2026) · Frontiers in Chemistry · doi:10.3389/fchem.2026.1861883
“Because of the drastically different Senescent Cell Anti-Apoptotic Pathways (SCAPs), it is biologically implausible to achieve broad-spectrum senolysis with a single agent (Gasek et al., 2021).”
ISTA strategy: A hierarchical nanosystem empowers sequential senotherapy in lung cancer
Yao, P., Wang, S., Wang, S., 全正扬, Li, W., Chen, X., Fan, Y., Sun, M., Zhang, C., Xing, P., et al. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2026.100549
Cellular senescence at the bidirectional interface between ageing and coronary artery disease
Li, X., Zhang, H., Chen, M., Wang, Y., Wang, K., Xu, X., Wang, J., Zhu, Q., Zhao, C., Wang, C., et al. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103284
Brain aging clocks: From methodological advances to cellular mechanisms
Suk, K. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113260
Wang, X., Li, X., Ling, L., Hayashi, T., Mizuno, K., Hattori, S., Fujisaki, H., Liu, W., & Ikejima, T. (2026) · Connective Tissue Research · doi:10.1080/03008207.2026.2712480
Cheng, Y., Jia, Y., & Zhou, L. (2026) · ACS Food Science & Technology · doi:10.1021/acsfoodscitech.6c00442
Senolytics and senomorphics: emerging therapeutic strategies
Fatima, R., Maqbool, M., Rana, A. J., & Hussain, M. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45811-8.00002-7
Mposhi, A., Uvnäs‐Moberg, K., & Turner, J. D. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103343
Endothelial RANK signaling triggers bone marrow inflammaging through IL-1β expressionPreprint
Kobayashi, Y., Iwamoto, R., Takahashi, T., Ishida, M., He, Z., Murakami, K., Hara, T., Ganbaatar, B., Yamagami, H., Endo, I., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10899322/v1
Endothelial RANK signaling triggers bone marrow inflammagingPreprint
Kobayashi, Y., Iwamoto, R., Takahashi, T., Ishida, M., He, Z., Murakami, K., Hara, T., Ganbaatar, B., Yamagami, H., Endo, I., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10285332/v1
Li, S., & Chen, B. (2026) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2026.106400
Babaali, A., Majdrezaei, Z., Javad-Khayat, Y., Fereidooni, S., & Mirzapoor, A. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100742
Wei, X., Cao, F.-F., Zhang, L.-Y., Chen, M.-Y., Zeng, C., Yang, S., & Guo, L. (2026) · Research Square · doi:10.21203/rs.3.rs-10880328/v1
Multidimensional Regulatory Network of Cellular Senescence: From Mechanisms to Theranostics
Lv, Z., Liu, Y., Liu, Y., Tan, Y., Man, Y., Shuqing, D., Zhang, Z., Lee, L. P., Chen, Q., & Liu, Z. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6c00849
Liu, F., Zhong, A., Li, J., Sun, Q., Fan, X., Fan, W., Tong, X., Liang, Y., Wang, X., Huang, D., et al. (2026) · Journal of Pineal Research · doi:10.1111/jpi.70185
“Under pathological conditions such as diabetes, senescent cells accumulate in multiple organs, contributing to tissue dysfunction and pathological manifestations [48, 49].”
Trigueiro, R. L., Oliveira, L. G. D. H., & Pantoja, P. D. S. (2026) · Advances in Geriatric Medicine and Research · doi:10.20900/agmr20260025
“Cardiovascular and neurodegenerative diseases are among the major pathological conditions associated with these interconnected mechanisms of aging [73,75,76].”
Li, X., Fu, Z., Sun, D., Jin, Z., & Jiao, H. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112258 · Cited by 1
Zhang, S., Zhang, C., Mao, J., & Ni, J. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108478
Blanco, J. R., & Carnero, A. (2026) · Cancers · doi:10.3390/cancers18193084
“This concern has stimulated the development of senomorphic therapies, which suppress the deleterious features of senescence, particularly the SASP, while preserving stable cell-cycle arrest [105].”
InfluentialChimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases
Fan, Z., Zheng, X., Jin, C., Zhang, J., Gong, N., & Li, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02783-5
“370,371 However, this diversity may enable precision targeting of speci fi c senescent subpopulations.”
Huang, J., Ji, L., Jin, H., Shi, Z., Song, X., Cai, Y., & Tong, X. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103398
Li, L., Fan, G., Zhao, R., Zhao, X., Yitong, C., Zhao, J., Lei, L., & Jianhua, F. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12792-w
“A staged strategy is more defen - sible: reduce upstream haemodynamic and metabolic stress, restore endothelial homeostatic signalling, constrain persis - tent SASP/redox amplification, and consider senescent-cell clearance only when cell type, disease stage and safety are adequately defined [70].”
Chmielewski, P. P., & Strzelec, B. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27208987
“Cellular senescence comprises durable proliferative arrest accompanied by variable changes in chromatin, metabolism, lysosomes, morphology, resistance to apoptosis, and secretion [49,50].”
Li, Y., Zhu, T., Lin, D., Cao, C., Wang, Q., Wang, J., Hu, L., Yu, Y., Huang, H., Wei, D., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.049236
Wei, C., & Xiong, X. (2026) · Journal of Cellular Physiology · doi:10.1002/jcp.70245
“Consequently, there is growing interest in behavioral interventions such as exercise because of their accessibility and non‐pharmacological nature (Jak 2012; Gasek et al. 2021).”
Metadata
- Authors
- Gasek, N. S., Kuchel, G. A., Kirkland, J. L., & Xu, M.
- Affiliations
- University of Connecticut (US)
- Mayo Clinic (US)
- Corresponding author
- Xu, Ming
- Venue
- Nature Aging
- Published
- 2021-10-07
- Volume
- 1
- Issue
- 10
- Pages
- 870-879
- ISSN
- 2662-8465 (ISSN-L)
- PMC
- PMC8612694
- OpenAlex
- W3202997660
- Cited by
- 501
- References
- 152
- Citations by year
- 2026: 78 · 2025: 120 · 2024: 141 · 2023: 95 · 2022: 63 · 2021: 4
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Aging (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute on Aging (R21AG063528,R33AG061456, R37AG013925, R01AG072301, P01AG062413, R21AG063528,R03AG072374,R01AG066679, R01AG068860)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, senolytics, senescence-associated secretory phenotype, senolytic therapy, senotherapeutics, aging, age-related diseases, intracellular signaling, bench-to-bedside translation, chronic disease
- MeSH terms
- Senescence-Associated Secretory Phenotype, Aging, Cell Differentiation, Chronic Disease, Humans, Signal Transduction, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
